Home/Filings/4/0001493152-18-003187
4//SEC Filing

Richard Gregory 4

Accession 0001493152-18-003187

CIK 0001054102other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 5:30 PM ET

Size

11.6 KB

Accession

0001493152-18-003187

Insider Transaction Report

Form 4
Period: 2018-02-26
Richard Gregory
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2018-03-07+28,00031,241 total
  • Exercise/Conversion

    Restricted Stock Units

    2018-02-262,0002,000 total
    Common Stock (2,000 underlying)
  • Award

    Stock Option (right to buy)

    2018-03-07+112,000112,000 total
    Exercise: $1.01Exp: 2028-03-07Common Stock (112,000 underlying)
  • Exercise/Conversion

    Common Stock

    2018-02-26+2,0003,241 total
Footnotes (4)
  • [F1]Mr. Richard received 6,000 restricted stock units on February 26, 2016. 2,000 restricted stock units vested and 759 restricted stock units were withheld for taxes before Mr. Richard was required to report his holdings, 2,000 restricted stock units vested on February 26, 2018 and the remaining 2,000 restricted stock units will vest on February 26, 2019.
  • [F2]Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer").
  • [F3]The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019.
  • [F4]The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer.

Documents

1 file

Issuer

Interpace Diagnostics Group, Inc.

CIK 0001054102

Entity typeother

Related Parties

1
  • filerCIK 0001717470

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:30 PM ET
Size
11.6 KB